Literature DB >> 31456860

Value of the Filtration Fraction Assessed by Dynamic 99mTc-Diethylenetriaminepentaacetic Acid Renal Scintigraphy After Angiotensin-Converting Enzyme Inhibition for the Diagnosis of Renovascular Hypertension.

Eonwoo Shin1, Changhwan Sung1, Hye Joo Son1, Dong Yun Lee1, Sun Young Chae1, Dae Hyuk Moon1.   

Abstract

PURPOSE: This study aimed to determine the diagnostic value of the relative filtration fraction (RFF) assessed by dynamic 99mTc-diethylenetriaminepentaacetic acid (99mTc-DTPA) renal scintigraphy after angiotensin-converting enzyme (ACE) inhibition for renovascular hypertension (RVHT) diagnosis.
METHODS: 99mTc-DTPA captopril renal scintigraphy performed in adolescents or adults (≥ 10 years) with suspected RVHT was retrospectively reviewed. The RFF of the affected kidney was qualitatively assessed as the relative glomerular filtration rate during the 2 to 3-min period compared with the relative perfusion during the first 60 s (qualitative RFF) and scored from 1 (definitely same) to 5 (definitely decreased). The quantitative RFF of the affected kidney was obtained by dividing the percentage of glomerular filtration rate by the percentage of renal perfusion.
RESULTS: Overall, 173 patients (high probability, n = 15; and low probability, n = 158) were included based on conventional captopril renal scintigraphic criteria. An abnormal qualitative RFF was observed in 12 patients with high probability, and the diagnostic sensitivity was 80.0% (95% CI, 51.9-95.7). The RFF was normal in 152 patients with low probability, and the diagnostic specificity was 96.2% (95% CI, 91.9-98.6). The RFF was lower in patients with high probability than in those with low probability (0.79 ± 0.15 vs. 1.02 ± 0.11, P < 0.0001).
CONCLUSIONS: The RFF assessed by dynamic 99mTc-DTPA renal scintigraphy after ACE inhibition can detect patients with high probability for RVHT. The RFF after ACE inhibition might be a useful diagnostic criterion especially when baseline scintigraphy is not available for evaluating ACE inhibition-induced changes.

Entities:  

Keywords:  99mTc-diethylenetriaminepentaacetic acid renal scintigraphy; Angiotensin-converting enzyme inhibition; Filtration fraction; Renovascular hypertension

Year:  2019        PMID: 31456860      PMCID: PMC6694321          DOI: 10.1007/s13139-019-00595-w

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  28 in total

1.  Treatment of atherosclerotic renal artery stenosis: time for a new approach.

Authors:  Peter W de Leeuw; Cornelis T Postma; Abraham A Kroon
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

2.  ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis.

Authors:  Georgios Karanikas; Alexander Becherer; Karoline Wiesner; Robert Dudczak; Kurt Kletter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

Review 3.  Renovascular hypertension and ischemic nephropathy.

Authors:  Stephen C Textor; Lilach Lerman
Journal:  Am J Hypertens       Date:  2010-09-23       Impact factor: 2.689

4.  Models of renal blood flow and their use in the detection of renal artery stenosis.

Authors:  S T Chandler; C J Gibson; L Elliott
Journal:  Nucl Med Commun       Date:  1990-06       Impact factor: 1.690

5.  Noninvasive measurement of renal blood flow with technetium-99m-DTPA in the evaluation of patients with suspected renovascular hypertension.

Authors:  A M Peters; J Brown; D Crossman; A J Brady; A P Hemingway; M E Roddie; D J Allison
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

6.  Revascularization versus medical therapy for renal-artery stenosis.

Authors:  Keith Wheatley; Natalie Ives; Richard Gray; Philip A Kalra; Jonathan G Moss; Colin Baigent; Susan Carr; Nicholas Chalmers; David Eadington; George Hamilton; Graham Lipkin; Anthony Nicholson; John Scoble
Journal:  N Engl J Med       Date:  2009-11-12       Impact factor: 91.245

7.  Prognostic value of captopril renal scintigraphy in renovascular hypertension.

Authors:  M Dondi; S Fanti; A De Fabritiis; A Zuccala; R Gaggi; M Mirelli; A Stella; M Marengo; F Losinno; N Monetti
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

8.  Prevalence of renovascular disease in the elderly: a population-based study.

Authors:  Kimberley J Hansen; Matthew S Edwards; Timothy E Craven; Gregory S Cherr; Sharon A Jackson; Richard G Appel; Gregory L Burke; Richard H Dean
Journal:  J Vasc Surg       Date:  2002-09       Impact factor: 4.268

9.  Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.

Authors:  Liesbeth Bax; Arend-Jan J Woittiez; Hans J Kouwenberg; Willem P T M Mali; Erik Buskens; Frederik J A Beek; Branko Braam; Frans T M Huysmans; Leo J Schultze Kool; Matthieu J C M Rutten; Cornelius J Doorenbos; Johannes C N M Aarts; Ton J Rabelink; Pierre-François Plouin; Alain Raynaud; Gert A van Montfrans; Jim A Reekers; Anton H van den Meiracker; Peter M T Pattynama; Peter J G van de Ven; Dammis Vroegindeweij; Abraham A Kroon; Michiel W de Haan; Cornelis T Postma; Jaap J Beutler
Journal:  Ann Intern Med       Date:  2009-05-04       Impact factor: 25.391

Review 10.  Refining the approach to renal artery revascularization.

Authors:  Robert D Safian; Ryan D Madder
Journal:  JACC Cardiovasc Interv       Date:  2009-03       Impact factor: 11.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.